molecular-weight heparin
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed methods study
12
Protective Effect of Ultra Low Molecular Weight Heparin on Glutamate Induced Apoptosis in Cortical Cells
10
Comparative Study for Preventive Effects of Intra Abdominal Adhesion Using Cyclo Oxygenase 2 Enzyme (COX 2) Inhibitor, Low Molecular Weight Heparin (LMWH), and Synthetic Barrier
7
Low molecular weight heparin prophylaxis: a boon for women with history of placental mediated complications
5
Original Article Efficacy and safety of low molecular weight heparin treatment, intermittent pneumatic compression therapy passive ankle exercise and nursing care in preventing deep venous thrombosis of the lower extremity following varicose vein surgery
9
ALIFE2 study: low molecular weight heparin for women with recurrent miscarriage and inherited thrombophilia study protocol for a randomized controlled trial
10
A study to assess the effectiveness of cold compression on pain and ecchymosis on patients getting subcutaneous low molecular weight heparin in a selected tertiary care hospital
5
Original Article Clinical research on chemotherapy in combination with LMWH treatment of advanced lung cancer patients
10
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications
8
Impact of Pharmaceutical Care on Self Administration of Outpatient Low Molecular Weight Heparin Therapy
14
HIV complicated meningovascular syphilis: Atypical symptoms with promising result using low molecular weight heparin
5
Recurrent Implantation Failure and Low Molecular Weight Heparin
17
Role of low molecular weight heparin in treatment of acute pancreatitis
156
Hepatic uptake of a modified low molecular weight heparin in rats
8
Middle Molecular Weight Heparinyl Amino Acid Derivatives (MHADs) Function as Indirect Radical Scavengers in Vitro
7
PHARMACOKINETIC PARAMETERS TO BE EVALUATED FOR SELECTED LOW MOLECULAR WEIGHT HEPARINs IN BIOEQUIVALENCE STUDIES Chaitanya Gadiko*, Satyanarayana Thota and Sudhakar K Tippabotla Clinical Pharmacology and Pharmacokinetics, Integrated Product Development, Dr Reddy’s Laboratories Limited, Hyderabad 500 090, Andhra Pradesh, India
8
NOVEL NANOPARTICLES FOR THE ORAL DELIVERY OF LOW MOLECULAR WEIGHT HEPARIN: IN VITRO AND IN VIVO ASSESSMENT
8
Effects of 8,000 IU aXa long term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease – a post hoc analysis of the PARAT trial
5
Pathways for outpatient management of venous thromboembolism in a UK centre.
8
INCIDENCE OF HEPARIN INDUCED THROMBOCYTOPENIA IN A TERTIARY HOSPITAL
11